Michelle Shayne, M.D.
See information for Patients. Viewing information for Researchers.
Contact
University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, New York 14642
Office: 585 275-5863
Fax: 585 273-5761
Current Appointments
- Assistant Professor - Department of Medicine (SMD)
| Education | ||
|---|---|---|
| MD Medicine | Univ Rochester Sch Med/Dent | 1998 |
| MM Arts & Sciences | The Juilliard School | 1987 |
| BMus Arts & Sciences | University of Rochester | 1985 |
| Post-Doctoral Training & Residency | |
|---|---|
| Harvard School of Public Health Clinical Effectiveness Training Program | 2003 - 2003 |
| Fellowship in Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Boston, MA | 2001 - 2004 |
| Residency in Internal Medicine, Strong Memorial Hospital, Rochester, NY. | 1998 - 2001 |
| Board Certifications | |
|---|---|
| Medical Oncology, American Board of Internal Medicine | 2005 - Present |
| Internal Medicine, American Board of Internal Medicine | 2001 - Present |
| Recent Journal Articles |
|---|
| Showing the 5 most recent journal articles. (7 available) |
| Lo S, Khorana A, Milind J, Simon S, Gauri K, Rajasenan K, Wang H, Hantel A, Shayne M, Hwang J, Schmotzer A, Ramanathan R. "A phase II study of weekly docetaxel in combination with capecitabine in Advanced gastric and gastro-esophageal adenocarcinomas." Oncology (2009). |
| Shayne M, Culakova E, Wolff D, Poniewierski M, Dale D, Crawford J, Lyman G. "Dose intensity in older breast cancer patients receiving systemic chemotherapy." Cancer (2009). |
| Rao MV; Shayne M. "Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer." Breast cancer research and treatment. 2008; Epub 2008 Jul 01. |
| Aivado M; Spentzos D; Germing U; Alterovitz G; Meng XY; Grall F; Giagounidis AA; Klement G; Steidl U; Otu HH; Czibere A; Prall WC; Iking-Konert C; Shayne M; Ramoni MF; Gattermann N; Haas R; Mitsiades CS; Fung ET; Libermann TA. "Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease." Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(4):1307-12. Epub 2007 Jan 12. |
| Lyman GH; Shayne M. "Granulocyte colony-stimulating factors: finding the right indication." Current opinion in oncology. 2007; 19(4):299-307. |
